SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Nash, Peter [1 ]
Kavanaugh, Arthur [2 ]
Buch, Maya [3 ]
Combe, Bernard [4 ]
Bessette, Louis [5 ]
Song, In-Ho [6 ]
Song, Yanna [6 ]
Suboticki, Jessica [6 ]
Fleischmann, Roy [7 ]
机构：
[1] Griffith Univ, Brisbane, Qld, Australia
[2] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA
[3] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Machester, England
[4] Univ Montpellier, Montpellier, France
[5] Laval Univ, Quebec City, PQ, Canada
[6] Abbvie Inc, N Chicago, IL USA
[7] Southwestern Med Ctr, Metroplex Clin Res Ctr, Dallas, TX USA
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P107
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [41] Molecular signature of methotrexate response among rheumatoid arthritis patients
    Brynedal, Boel
    Yoosuf, Niyaz
    Ulfarsdottir, Tinna Bjorg
    Ziemek, Daniel
    Maciejewski, Mateusz
    Folkersen, Lasse
    Westerlind, Helga
    Mueller, Malin
    Sahlstrom, Peter
    Jelinsky, Scott A.
    Hensvold, Aase
    Padyukov, Leonid
    Pomiano, Nancy Vivar
    Catrina, Anca
    Klareskog, Lars
    Berg, Louise
    FRONTIERS IN MEDICINE, 2023, 10
  • [42] Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis
    Fleischmann, Roy M.
    Blanco, Ricardo
    Hall, Stephen
    Thomson, Glen T. D.
    Van den Bosch, Filip E.
    Zerbini, Cristiano
    Bessette, Louis
    Enejosa, Jeffrey
    Li, Yihan
    Song, Yanna
    DeMasi, Ryan
    Song, In-Ho
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (04) : 432 - 439
  • [43] IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY
    Mysler, E.
    Tanaka, Y.
    Kavanaugh, A.
    Aletaha, D.
    Taylor, P. C.
    Song, I. H.
    Shaw, T.
    Song, Y.
    Demasi, R.
    Ali, M.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 566 - 567
  • [44] Impact of Upadacitinib or Adalimumab as Initial Therapy on the Achievement of 48-Week Treatment Goals in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Post Hoc Analysis of a Phase 3 Study
    Mysler, Eduardo
    Tanaka, Yoshiya
    Kavanaugh, Arthur
    Aletaha, Daniel
    Taylor, Peter
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    DeMasi, Ryan
    Ali, Mira
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [45] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Stephanie F. Ling
    Nisha Nair
    Suzanne M. M. Verstappen
    Anne Barton
    Hans-Dieter Zucht
    Petra Budde
    Peter Schulz-Knappe
    Darren Plant
    The Pharmacogenomics Journal, 2020, 20 : 516 - 523
  • [46] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [47] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
    Buch, Maya H.
    Walker, David
    Edwards, Christopher J.
    Barry, Jane
    Akroyd, Laura
    Omoruyi, Edmund V. Ekoka
    Taylor, Peter C.
    RHEUMATOLOGY, 2024,
  • [48] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [49] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Sakamaki, Yoshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S475
  • [50] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Ling, Stephanie F.
    Nair, Nisha
    Verstappen, Suzanne M. M.
    Barton, Anne
    Zucht, Hans-Dieter
    Budde, Petra
    Schulz-Knappe, Peter
    Plant, Darren
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 516 - 523
12345